Patent Filing Costs. 26 9.3. Cooperation ............................................ 26 9.4. Notification of Patent Term Restoration ................ 27 9.5. No Other Technology Rights ............................. 27 9.6. Enforcement of Patent Rights; Defense of Infringement Actions ................................... 27 9.6.1. First
Patent Filing Costs. All costs associated with filing, prosecuting and maintaining patent applications and patents covering each of GelTex and Genzyme's Patent Rights specific to the Field shall be deemed Development Costs; provided, however, that if the claims of any such Patent Rights include claims outside the Field, each of RenaGel LLC and the Party filing, prosecuting and maintaining such patents and patent applications shall bear one-half (1/2) of such costs.
Patent Filing Costs shall bear all costs associated with filing, prosecuting and maintaining patent applications and patents covering the TKT Patent Rights in all countries in the MMD Territory.
Patent Filing Costs. All costs associated with filing, prosecuting and maintaining patent applications and patents covering each of Dyax and Genzyme's Patent Rights and the Joint Patent Rights specific to the Field in the Territory (including costs relating to patent oppositions, interferences, reexaminations and reissues) shall be deemed Development Costs; PROVIDED, HOWEVER, that if the subject matter of any such Patent Rights would include claims outside the Field, one-half (1/2) of such costs shall be deemed Development Costs.
Patent Filing Costs. All reasonable and documented costs incurred after the Effective Date and associated with filing, prosecuting and maintaining patent applications and patents covering each of GelTex's Patent Rights with claims applicable to the Field in the Territory shall be paid by [ * ].
Patent Filing Costs. TKT shall bear all costs associated with filing, prosecuting (including defense of oppositions) and maintaining patent applications and patents covering the TKT Patent Rights in all countries in the Territory, except as otherwise provided in Section 9.2(a).
Patent Filing Costs. All costs associated with filing, ------------------- prosecuting and maintaining patent applications and patents covering each of the BioMarin Patent Rights, Genzyme Patent Rights and BioMarin/Genzyme Patent Rights specific to the Collaboration Products in the Territory shall be deemed Development Costs; provided, however, that if any such Patent Rights include claims directed at subject matter other than Collaboration Products, one-half (1/2) of the costs incurred for the filing, prosecution and maintaining of such Patent Rights shall be deemed Development Costs. For purposes of this Section 9.2, "prosecution and maintenance" of Patent Rights shall be deemed to include, without limitation, the conduct of interferences or oppositions, and/or requests for re-examinations, reissues or extensions of patent terms.
Patent Filing Costs. All costs and expenses incurred after the Effective Date of filing, prosecuting, maintaining and extending those Elan Patents or Biogen Patents which related specifically to Licensed Product or to the manufacture or use of Licensed Product and all Collaboration Invention Patent Rights shall be treated as Other Out of Pocket Costs and shall be shared by the Parties as part of Reimbursable Commercial Costs in accordance with their respective Percentages as set forth in Section 6.2. Notwithstanding the foregoing, any expenses related to those Elan Patent Rights or Biogen Patent Rights that are not specifically related to Licensed Products shall not be shared by the Parties.
Patent Filing Costs. 24 8.3. Cooperation............................................ 24 8.4. Notification of Patent Term Restoration................ 24 8.5. No Other Technology Rights............................. 25 8.6. Enforcement of TKT Patent Rights and TKT Technology; Defense of Infringement Actions............ 25 8.6.1. MMD's First Right to Respond........... 25 8.6.2. No Adverse Settlement without TKT Consent................................ 25 8.6.3. Sharing of Litigation and Settlement Expenses............................... 25 8.6.4. TKT's Second Right to Respond.......... 26 8.6.5. TKT's Second Right to Defend Infringement Actions; Payment of Royalties by TKT....................... 26 8.7. Costs of Acquiring Additional Technology other than Manufacturing Know-How............................ 26 ARTICLE 9. CONFIDENTIALITY................................................ 27 9.1. Nondisclosure Obligations.............................. 27 9.1.1. General................................ 27 9.1.2. Limitations............................ 27 (iii) CONFIDENTIAL MATERIAL OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSIONS.
Patent Filing Costs. All Patent Costs incurred after the Effective Date of filing, prosecuting, maintaining and extending those ICOS Relevant Patent Claims or Biogen Relevant Patent Claims and all Collaboration Invention Patent Rights [ * ], and shall be shared by the Parties as part of Reimbursable Commercial Costs in accordance with their respective Percentages as set forth in Section 6.2. Notwithstanding the foregoing, any expenses related to claims in ICOS Patents that are not ICOS Relevant Patent Claims or claims in Biogen Patents that are not Biogen Relevant Patent Claims shall not be shared by the Parties.
